Skip to main content
Erschienen in: Neurological Sciences 8/2017

01.08.2017 | Review Article

Autism, epilepsy, and synaptopathies: a not rare association

verfasst von: Roberto Keller, Roberta Basta, Luana Salerno, Maurizio Elia

Erschienen in: Neurological Sciences | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Autism spectrum disorders (ASD) are neurodevelopmental disorders typically diagnosed in childhood, characterized by core social dysfunction, rigid and repetitive behaviors, restricted interests, and abnormal sensorial sensitivity. ASD belong to multifactorial diseases: both genetic and environmental factors have been considered as potential risk factors for their onset. ASD are often associated with neurological conditions: the co-occurrence of epilepsy is well documented and there is also evidence of a higher prevalence of EEG abnormalities with 4–86% of individuals with ASD presenting epileptiform or not epileptiform EEG abnormalities. The presence of epilepsy in people with ASD may be determined by several structural alterations, genetic conditions, or metabolic dysfunctions, known to play a role in the emergence of both epilepsy and autism. The purpose of this article is to discuss precisely such latter cause of the autism–epilepsy association, focusing specifically on those “synaptic genes,” whose mutation predisposes to both the diseases.
Literatur
1.
Zurück zum Zitat Keller R (2016) I disturbi dello spettro autistico in adolescenza e in età adulta. Erikson, Trento Keller R (2016) I disturbi dello spettro autistico in adolescenza e in età adulta. Erikson, Trento
3.
Zurück zum Zitat Fassio A, Patry L, Congia S, Onofri F, Piton A, Gauthier J, Pozzi D, Messa M, Defranchi E, Fadda M, Corradi A, Baldelli P, Lapointe L, St-Onge J, Meloche C, Mottron I, Valtorta F, Nguyen D, Rouleau G, Benfenati F, Cossette P (2011) SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet 20(12):2297–2307. doi:10.1093/hmg/ddr122 Fassio A, Patry L, Congia S, Onofri F, Piton A, Gauthier J, Pozzi D, Messa M, Defranchi E, Fadda M, Corradi A, Baldelli P, Lapointe L, St-Onge J, Meloche C, Mottron I, Valtorta F, Nguyen D, Rouleau G, Benfenati F, Cossette P (2011) SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet 20(12):2297–2307. doi:10.​1093/​hmg/​ddr122
6.
13.
15.
Zurück zum Zitat Russo E, Follesa P, Citraro R, Camastra C, Donato A, Isola D et al (2014) The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model. Neurol Sci 35(11):1793–1799CrossRefPubMed Russo E, Follesa P, Citraro R, Camastra C, Donato A, Isola D et al (2014) The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model. Neurol Sci 35(11):1793–1799CrossRefPubMed
16.
Zurück zum Zitat Canitano R (2014) Autism with epilepsy: a neurodevelopmental association. OA Autism 2(1):7 Canitano R (2014) Autism with epilepsy: a neurodevelopmental association. OA Autism 2(1):7
17.
Zurück zum Zitat McMahan J, Yu W, Yang J, Feng H, Helm M, McMaham E, Zhu X, Shin D, Huang Y (2015) Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice. Neurobialogy Diseases 73:296–306. doi:10.1016/j.nbd.2014.10.004 CrossRef McMahan J, Yu W, Yang J, Feng H, Helm M, McMaham E, Zhu X, Shin D, Huang Y (2015) Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice. Neurobialogy Diseases 73:296–306. doi:10.​1016/​j.​nbd.​2014.​10.​004 CrossRef
18.
Zurück zum Zitat Talos D, Sun H, Zhou X, Fitzgeralg E, Jackson M, Klein P, Lan V, Joseph A, Jensen F (2012) The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLOSONE 7(5):e35885. doi:10.1371/journal.pone.0035885 CrossRef Talos D, Sun H, Zhou X, Fitzgeralg E, Jackson M, Klein P, Lan V, Joseph A, Jensen F (2012) The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLOSONE 7(5):e35885. doi:10.​1371/​journal.​pone.​0035885 CrossRef
21.
Zurück zum Zitat Rasmussen S., Friedman J. (2000) NF1 gene and neurofibromatosis 1. American Journal of Epidemiology 1;151(1):33-40 Rasmussen S., Friedman J. (2000) NF1 gene and neurofibromatosis 1. American Journal of Epidemiology 1;151(1):33-40
26.
Zurück zum Zitat Christodoulou J. Ho G. (2001) MECP-related disorders. GeneReviews Christodoulou J. Ho G. (2001) MECP-related disorders. GeneReviews
28.
Zurück zum Zitat Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, Kwok S-m, Feldman DA, Bateup HS, Gao Q, Hockemeyer D, Mitalipova M, Lewis CA, Vander MG, Heiden MS, Young RA, Jaenisch R (2013) Global transcriptional and translational repression in human-embryonic stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13(4):446–458. doi:10.1016/j.stem.2013.09.001 CrossRefPubMedPubMedCentral Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, Kwok S-m, Feldman DA, Bateup HS, Gao Q, Hockemeyer D, Mitalipova M, Lewis CA, Vander MG, Heiden MS, Young RA, Jaenisch R (2013) Global transcriptional and translational repression in human-embryonic stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13(4):446–458. doi:10.​1016/​j.​stem.​2013.​09.​001 CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Shahbazian M, Antalffy B, Armstrom D, Zoghbi H (2002) Insight into Rett syndrome: MeCP2 levels display tissue and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11(2):115–124CrossRefPubMed Shahbazian M, Antalffy B, Armstrom D, Zoghbi H (2002) Insight into Rett syndrome: MeCP2 levels display tissue and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11(2):115–124CrossRefPubMed
30.
Zurück zum Zitat Szafranski P, Golla S, Jin W, Fang P, Hixson P, Matalon R, Kinney D, Bock H, Craigen W, Smith J, Bi W, Patel A, Cheung S, Bacino C, Stankiewicz P (2015) Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications. Eur J Hum Genet 23(7):915–921. doi:10.1038/ejhg.2014.217 CrossRefPubMed Szafranski P, Golla S, Jin W, Fang P, Hixson P, Matalon R, Kinney D, Bock H, Craigen W, Smith J, Bi W, Patel A, Cheung S, Bacino C, Stankiewicz P (2015) Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications. Eur J Hum Genet 23(7):915–921. doi:10.​1038/​ejhg.​2014.​217 CrossRefPubMed
32.
Zurück zum Zitat Figura MG, Coppola A, Bottitta M, Calabrese G, Grillo L, Luciano D, Del Gaudio L, Torniero C, Striano S, Elia M (2014) Seizures and EEG pattern in the 22q13.3 deletion syndrome: clinical report of six italian cases. Seizure 23(9):774–779. doi:10.1016/j.seizure.2014.06.008 CrossRefPubMed Figura MG, Coppola A, Bottitta M, Calabrese G, Grillo L, Luciano D, Del Gaudio L, Torniero C, Striano S, Elia M (2014) Seizures and EEG pattern in the 22q13.3 deletion syndrome: clinical report of six italian cases. Seizure 23(9):774–779. doi:10.​1016/​j.​seizure.​2014.​06.​008 CrossRefPubMed
41.
Zurück zum Zitat Paonessa F, Latifi S, Scarangella H, Cesca F, Benfenalti F (2012) Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene (SYN1) is modulated by RE-1 silencing transcription factor (REST) and 5′-cytosine-phosphoguanine (Cpg) methylation. J Biol Chem 288(5):3227–3239. doi:10.1074/jbc.M112.399782 CrossRefPubMedPubMedCentral Paonessa F, Latifi S, Scarangella H, Cesca F, Benfenalti F (2012) Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene (SYN1) is modulated by RE-1 silencing transcription factor (REST) and 5′-cytosine-phosphoguanine (Cpg) methylation. J Biol Chem 288(5):3227–3239. doi:10.​1074/​jbc.​M112.​399782 CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Curran S, Ahn JW, Grayton H, Collier D, Ogilvie CM (2013) NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series—further understanding of the relevance of NRXN1 to neurodevelopmental disorders. Journal of Molecular Psychiatry 1(1):4. doi:10.1186/2049-9256-1-4 CrossRefPubMedPubMedCentral Curran S, Ahn JW, Grayton H, Collier D, Ogilvie CM (2013) NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series—further understanding of the relevance of NRXN1 to neurodevelopmental disorders. Journal of Molecular Psychiatry 1(1):4. doi:10.​1186/​2049-9256-1-4 CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Novarino G, El-Fishawy P, Kayserili H, Meguid N, Scott E, Schroth J, Silhavy J, Kara M, Khaili R, Ben-Omran T, Ercan SA, Hashish A, Senders S, Gupta A, Hashem H, Matern D, Gabriel S, Sweetman L, Rahimi Y, Harris R, State MW, Gleeson J (2012) Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science 338(6105):394–397. doi:10.1126/science.1224631 CrossRefPubMedPubMedCentral Novarino G, El-Fishawy P, Kayserili H, Meguid N, Scott E, Schroth J, Silhavy J, Kara M, Khaili R, Ben-Omran T, Ercan SA, Hashish A, Senders S, Gupta A, Hashem H, Matern D, Gabriel S, Sweetman L, Rahimi Y, Harris R, State MW, Gleeson J (2012) Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science 338(6105):394–397. doi:10.​1126/​science.​1224631 CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Weiss L, Escayg A, Kearney J, Trudean M, MacDonald B, Mori M, Reichert J, Buxbaum J, Meister M (2003) Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry 8(2):186–194CrossRefPubMed Weiss L, Escayg A, Kearney J, Trudean M, MacDonald B, Mori M, Reichert J, Buxbaum J, Meister M (2003) Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry 8(2):186–194CrossRefPubMed
49.
Zurück zum Zitat Di Gregorio E, Riberi E, Belligni EF, Biamino E, Spielmann M, Ala U, Calcia A, Bagnasco I, Carli D, Gai G, Giordano M, Guala A, Keller R, Mandrile G, Arduino C, Maffè A, Naretto VG, Sirchia F, Sorasio L, Ungari S, Zonta A, Zacchetti G, Talarico F, Pappi P, Cavalieri S, Giorgio E, Mancini C, Ferrero M, Brussino A, Savin E, Gandione M, Pelle A, Giachino DF, De Marchi M, Restagno G, Provero P, Silengo MC, Grosso E, Buxbaum JD, Pasini B, De Rubeis S, Brusco A, Ferrero GB (2017) CNVs analysis in a cohort of isolated and syndromic DD/ID reveals novel genomic disorders, position effects and candidate disease genes. Clin Genet. doi:10.1111/cge.13009 PubMed Di Gregorio E, Riberi E, Belligni EF, Biamino E, Spielmann M, Ala U, Calcia A, Bagnasco I, Carli D, Gai G, Giordano M, Guala A, Keller R, Mandrile G, Arduino C, Maffè A, Naretto VG, Sirchia F, Sorasio L, Ungari S, Zonta A, Zacchetti G, Talarico F, Pappi P, Cavalieri S, Giorgio E, Mancini C, Ferrero M, Brussino A, Savin E, Gandione M, Pelle A, Giachino DF, De Marchi M, Restagno G, Provero P, Silengo MC, Grosso E, Buxbaum JD, Pasini B, De Rubeis S, Brusco A, Ferrero GB (2017) CNVs analysis in a cohort of isolated and syndromic DD/ID reveals novel genomic disorders, position effects and candidate disease genes. Clin Genet. doi:10.​1111/​cge.​13009 PubMed
Metadaten
Titel
Autism, epilepsy, and synaptopathies: a not rare association
verfasst von
Roberto Keller
Roberta Basta
Luana Salerno
Maurizio Elia
Publikationsdatum
01.08.2017
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 8/2017
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-017-2974-x

Weitere Artikel der Ausgabe 8/2017

Neurological Sciences 8/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.